We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $219M invested in Corvus Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
86% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 14
7% more funds holding
Funds holding: 57 → 61 (+4)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.06% less ownership
Funds ownership: 88.75% → 87.69% (-1.1%)
21% less capital invested
Capital invested by funds: $279M → $219M (-$59.1M)
Holders
61
Holders Change
+4
Holders Change %
+7.02%
% of All Funds
1.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
26
Reduced
14
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.04M |
| 2 |
BlackRock
New York
|
+$870K |
| 3 |
Renaissance Technologies
New York
|
+$720K |
| 4 |
CI
Cowen Inc
New York
|
+$543K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$438K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.59M |
| 2 |
Millennium Management
New York
|
-$3.08M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$990K |
| 4 |
Goldman Sachs
New York
|
-$390K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$146K |
